Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare ...
News-Medical.Net on MSN
St. Jude scientists identify new therapeutic target for high-risk pediatric leukemia
Acute myeloid leukemia driven by tandem duplications within the UBTF gene (UBTF-TD AML) is a high-risk pediatric cancer in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback